It has been shown that LAG-3 binding to MHC-II protects tumor cells from Fas-mediated apoptosis and drug-induced apoptosis, such as etoposide, by activating the MAPK/Erk pathway and the PI3K/Akt pathway (47). This evidence concerns the gene LAG3 and neoplasm.